Jakarta - PT Kimia Farma Tbk (KAEF) is ready to implement the Ministry of Health's decision to reduce the rate/price of polymerase chain reaction (PCR) tests based on the Circular of the Director-General Health Services No. HK.02.02/I/2824/2021 concerning the Highest Tariff Limit for Reserve Transcription Polymerase Chain Reaction (RT-PCR) examination, effective from Tuesday, August 17, 2021.

Kimia Farma President Director Verdi Budidarmo said the company welcomed the Ministry of Health to lower the PCR inspection service fee.

"Kimia Farma immediately implemented the government's directive on reducing PCR test rates as a form of our commitment to provide the best service for the people of Indonesia. This will make it easier for the public to access COVID-19 tests, which will lead to an overall improvement in Indonesia's health climate," he said in a statement on Thursday (19/8).

Meanwhile, Acting President Director of PT Kimia Farm